By analyzing the response of ADR-treated breast cancer cells, we found that overexpression of NDRG2 could inhibit proliferation, enhance DNA damage response, and promote apoptosis, all of which suggests the great potential of NDRG2 in increasing drug sensitivity of breast cancer cells. This evidence concerns the gene NDRG2 and breast cancer.